190 related articles for article (PubMed ID: 9445345)
1. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats.
Markgraf CG; Velayo NL; Johnson MP; McCarty DR; Medhi S; Koehl JR; Chmielewski PA; Linnik MD
Stroke; 1998 Jan; 29(1):152-8. PubMed ID: 9445345
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats.
Tsubokawa T; Solaroglu I; Yatsushige H; Cahill J; Yata K; Zhang JH
Stroke; 2006 Jul; 37(7):1888-94. PubMed ID: 16763180
[TBL] [Abstract][Full Text] [Related]
3. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia.
Hong SC; Goto Y; Lanzino G; Soleau S; Kassell NF; Lee KS
Stroke; 1994 Mar; 25(3):663-9. PubMed ID: 8128523
[TBL] [Abstract][Full Text] [Related]
5. Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis.
Kawamura M; Nakajima W; Ishida A; Ohmura A; Miura S; Takada G
Brain Res; 2005 Mar; 1037(1-2):59-69. PubMed ID: 15777753
[TBL] [Abstract][Full Text] [Related]
6. Temporal dependent neuroprotection with propentofylline (HWA 285) in a temporary focal ischemia model.
Johnson MP; McCarty DR; Chmielewski PA
Eur J Pharmacol; 1998 Apr; 346(2-3):151-7. PubMed ID: 9652354
[TBL] [Abstract][Full Text] [Related]
7. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
Candelario-Jalil E; González-Falcón A; García-Cabrera M; León OS; Fiebich BL
Brain Res; 2004 May; 1007(1-2):98-108. PubMed ID: 15064140
[TBL] [Abstract][Full Text] [Related]
8. Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion.
Tatlisumak T; Takano K; Carano RA; Miller LP; Foster AC; Fisher M
Stroke; 1998 Sep; 29(9):1952-8. PubMed ID: 9731623
[TBL] [Abstract][Full Text] [Related]
9. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
Sydserff SG; Borelli AR; Green AR; Cross AJ
Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
[TBL] [Abstract][Full Text] [Related]
10. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
Pei Z; Pang SF; Cheung RT
Stroke; 2003 Mar; 34(3):770-5. PubMed ID: 12624306
[TBL] [Abstract][Full Text] [Related]
11. Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia.
Li PA; Howlett W; He QP; Miyashita H; Siddiqui M; Shuaib A
Neurosci Lett; 1998 May; 247(1):17-20. PubMed ID: 9637399
[TBL] [Abstract][Full Text] [Related]
12. Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.
Schäbitz WR; Hoffmann TT; Heiland S; Kollmar R; Bardutzky J; Sommer C; Schwab S
Stroke; 2001 May; 32(5):1226-33. PubMed ID: 11340238
[TBL] [Abstract][Full Text] [Related]
13. Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration.
Bartus RT; Hayward NJ; Elliott PJ; Sawyer SD; Baker KL; Dean RL; Akiyama A; Straub JA; Harbeson SL; Li Z
Stroke; 1994 Nov; 25(11):2265-70. PubMed ID: 7974554
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
15. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
Shuaib A; Xu Wang C; Yang T; Noor R
Stroke; 2002 Dec; 33(12):3033-7. PubMed ID: 12468809
[TBL] [Abstract][Full Text] [Related]
16. Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury.
Ai J; Liu E; Wang J; Chen Y; Yu J; Baker AJ
J Neurotrauma; 2007 Jun; 24(6):960-78. PubMed ID: 17600513
[TBL] [Abstract][Full Text] [Related]
17. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats.
Xu L; Fagan SC; Waller JL; Edwards D; Borlongan CV; Zheng J; Hill WD; Feuerstein G; Hess DC
BMC Neurol; 2004 Apr; 4():7. PubMed ID: 15109399
[TBL] [Abstract][Full Text] [Related]
18. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia.
Seyfried DM; Veyna R; Han Y; Li K; Tang N; Betts RL; Weinsheimer S; Chopp M; Anagli J
Brain Res; 2001 May; 901(1-2):94-101. PubMed ID: 11368955
[TBL] [Abstract][Full Text] [Related]
19. Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats.
Mokudai T; Ayoub IA; Sakakibara Y; Lee EJ; Ogilvy CS; Maynard KI
Stroke; 2000 Jul; 31(7):1679-85. PubMed ID: 10884473
[TBL] [Abstract][Full Text] [Related]
20. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats.
Kuluz JW; Prado RJ; Dietrich WD; Schleien CL; Watson BD
Stroke; 1993 Dec; 24(12):2023-9. PubMed ID: 7504336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
